Watson Pharmaceuticals Inc. / Amarin Development AB (Amarin Corp subsidiary)
2003 · Asset Purchase · $150M · Complete
Announcement Sentiment
71
Positive
Acquired Amarin Development AB in October 2003. Oral controlled-release drug delivery technologies + glipizide ER. Sources: Watson 10-K 2003, Amarin filings. Value approximate from 10-K disclosures.